Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/172193
Title: Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients
Author: Rodríguez-Molinero, Alejandro
Gálvez-Barrón, César
Miñarro Alonso, Antonio
Macho, Oscar
López, Gabriela F.
Robles, Maria Teresa
Dapena, María Dolores
Martínez, Sergi
Milà Ràfols, Núria
Monaco, Ernesto E.
Hidalgo García, Antonio
Keywords: COVID-19
Terapèutica
COVID-19
Therapeutics
Issue Date: 15-Oct-2020
Publisher: Public Library of Science (PLoS)
Abstract: mportance The rapid pandemic expansion of the disease caused by the new SARS-CoV-2 virus has compromised health systems worldwide. Knowledge of prognostic factors in affected patients can help optimize care. Objective The objective of this study was to analyze the relationship between the prognosis of COVID-19 and the form of presentation of the disease, the previous pathologies of patients and their chronic treatments. Design, participants and locations This was an observational study on a cohort of 418 patients admitted to three regional hospitals in Catalonia (Spain). As primary outcomes, severe disease (need for oxygen therapy via nonrebreather mask or mechanical ventilation) and death were studied. Multivariate binary logistic regression models were performed to study the association between the different factors and the results. Results Advanced age, male sex and obesity were independent markers of poor prognosis. The most frequent presenting symptom was fever, while dyspnea was associated with severe disease and the presence of cough with greater survival. Low oxygen saturation in the emergency room, elevated CRP in the emergency room and initial radiological involvement were all related to worse prognosis. The presence of eosinophilia (% of eosinophils) was an independent marker of less severe disease. Conclusions This study identified the most robust markers of poor prognosis for COVID-19. These results can help to correctly stratify patients at the beginning of hospitalization based on the risk of developing severe disease.
Note: Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0239571
It is part of: PLoS One, 2020, vol. 15, num. 10, p. e0239571
URI: http://hdl.handle.net/2445/172193
Related resource: https://doi.org/10.1371/journal.pone.0239571
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Genètica, Microbiologia i Estadística)

Files in This Item:
File Description SizeFormat 
704650.pdf477.83 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons